(Q45982296)

English

Bridging science and health policy in cardiovascular disease: focus on lipid management: A Report from a Session held during the 7th International Symposium on Multiple Risk Factors in Cardiovascular Diseases: Prevention and Intervention--Health Pol

scientific article published in June 2009

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19497553

Bridging science and health policy in cardiovascular disease: focus on lipid management: A Report from a Session held during the 7th International Symposium on Multiple Risk Factors in Cardiovascular Diseases: Prevention and Intervention--Health Pol (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19497553

cardiovascular disease

1 reference

based on heuristic

inferred from title

Alberico L. Catapano

3

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19497553

6

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19497553

10

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19497553

Vincenzo Atella

object named as

V Atella

1

0 references

Julia A Critchley

object named as

J Critchley

4

0 references

object named as

P Lindgren

8

0 references

author name string

A Brady

2

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19497553

I M Graham

5

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19497553

J Leal

7

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19497553

D Vanuzzo

9

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19497553

D Wood

11

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19497553

R Paoletti

12

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19497553

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 June 2009

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19497553

Atherosclerosis. Supplements

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19497553

10

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19497553

1

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19497553

3-21

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19497553

Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2809%2970003-0

7 January 2021

based on heuristic

inferred from DOI database lookup

European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2809%2970003-0

7 January 2021

based on heuristic

inferred from DOI database lookup

European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by rep

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2809%2970003-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part II: Clinical trial evidence (acute coronary syndromes through renal disease) and future directions

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2809%2970003-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part I: Pathophysiology and clinical trial evidence (risk factors through stable coronary artery disease).

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2809%2970003-0

7 January 2021

based on heuristic

inferred from DOI database lookup

2008 white paper for implementing strategies and interventions for cardiovascular prevention in Italy

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2809%2970003-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2809%2970003-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2809%2970003-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Economic burden of cardiovascular diseases in the enlarged European Union

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2809%2970003-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The relation between funding by the National Institutes of Health and the burden of disease

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2809%2970003-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Cost of cardiovascular diseases in the United Kingdom

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2809%2970003-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Lipoproteins and atherogenesis. Current concepts

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2809%2970003-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Lipids and risk of coronary heart disease. The Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2809%2970003-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of coronary heart disease in the Framingham Offspring Study: role of lipoprotein cholesterols

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2809%2970003-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT).

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2809%2970003-0

7 January 2021

based on heuristic

inferred from DOI database lookup

By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2809%2970003-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of rosuvastatin therapy on coronary artery stenoses assessed by quantitative coronary angiography: a study to evaluate the effect of rosuvastatin on intravascular ultrasound-derived coronary atheroma burden.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2809%2970003-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2809%2970003-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2809%2970003-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensive lipid lowering with atorvastatin in patients with stable coronary disease

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2809%2970003-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2809%2970003-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Lipoprotein concentrations in newborns are associated with allelic variations in their mothers

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2809%2970003-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Pleiotropic effects of statins: benefit beyond cholesterol reduction? A meta-regression analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2809%2970003-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Sick individuals and sick populations

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2809%2970003-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2809%2970003-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Explaining the Decrease in U.S. Deaths from Coronary Disease, 1980–2000

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2809%2970003-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluating the impact of population and high-risk strategies for the primary prevention of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2809%2970003-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk assessment and lipid modification for primary and secondary prevention of cardiovascular disease: summary of NICE guidance

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2809%2970003-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Meta-analysis of the cholesterol-lowering effect of ezetimibe added to ongoing statin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2809%2970003-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Estimating the health benefits and costs associated with ezetimibe coadministered with statin therapy compared with higher dose statin monotherapy in patients with established cardiovascular disease: results of a Markov model for UK costs using data

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2809%2970003-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2809%2970003-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of medication adherence on hospitalization risk and healthcare cost

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2809%2970003-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The From The Heart study: a global survey of patient understanding of cholesterol management and cardiovascular risk, and physician-patient communication

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2809%2970003-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Lipid management in cardiovascular disease prevention guidelines: strategies and tactics for implementation.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2809%2970003-0

7 January 2021

based on heuristic

inferred from DOI database lookup

EUROASPIRE. A European Society of Cardiology survey of secondary prevention of coronary heart disease: principal results. EUROASPIRE Study Group. European Action on Secondary Prevention through Intervention to Reduce Events

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2809%2970003-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2809%2970003-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Adherence with statin therapy in elderly patients with and without acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2809%2970003-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term persistence in use of statin therapy in elderly patients

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2809%2970003-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2809%2970003-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Improvements in quality of clinical care in English general practice 1998-2003: longitudinal observational study

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2809%2970003-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Quality of Primary Care in England with the Introduction of Pay for Performance

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2809%2970003-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Low risk--and the "No more than 50%" myth/dogma

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2809%2970003-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1567-5688(09)70003-0

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19497553

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19497553

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45982296&oldid=2078524804"